- Home
- GNFT vs QBTS Comparison
GNFT vs QBTS Comparison
Compare GNFT & QBTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- QBTS
- Stock Information
- Founded
- GNFT 1999
- QBTS 1999
- Country
- GNFT France
- QBTS United States
- Employees
- GNFT N/A
- QBTS N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- QBTS Retail: Computer Software & Peripheral Equipment
- Sector
- GNFT Health Care
- QBTS Technology
- Exchange
- GNFT Nasdaq
- QBTS Nasdaq
- Market Cap
- GNFT 214.5M
- QBTS 5.0B
- IPO Year
- GNFT 2019
- QBTS N/A
- Fundamental
- Price
- GNFT N/A
- QBTS $16.68
- Analyst Decision
- GNFT Strong Buy
- QBTS Strong Buy
- Analyst Count
- GNFT 1
- QBTS 7
- Target Price
- GNFT $13.00
- QBTS $15.14
- AVG Volume (30 Days)
- GNFT 4.2K
- QBTS 52.7M
- Earning Date
- GNFT 04-24-2025
- QBTS 08-07-2025
- Dividend Yield
- GNFT N/A
- QBTS N/A
- EPS Growth
- GNFT N/A
- QBTS N/A
- EPS
- GNFT 0.03
- QBTS N/A
- Revenue
- GNFT $73,187,701.00
- QBTS $21,363,000.00
- Revenue This Year
- GNFT $15.98
- QBTS $181.95
- Revenue Next Year
- GNFT N/A
- QBTS $55.49
- P/E Ratio
- GNFT $125.14
- QBTS N/A
- Revenue Growth
- GNFT 105.01
- QBTS 121.61
- 52 Week Low
- GNFT $2.55
- QBTS $0.75
- 52 Week High
- GNFT $6.42
- QBTS $19.77
- Technical
- Relative Strength Index (RSI)
- GNFT 46.56
- QBTS 56.67
- Support Level
- GNFT $3.61
- QBTS $13.57
- Resistance Level
- GNFT $3.95
- QBTS $15.44
- Average True Range (ATR)
- GNFT 0.14
- QBTS 0.99
- MACD
- GNFT -0.01
- QBTS -0.27
- Stochastic Oscillator
- GNFT 50.64
- QBTS 70.84
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About QBTS D-Wave Quantum Inc.
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.